Evotec, Novo Nordisk Stem Cell Partnership
This is a Germany news story, published by Yahoo Finance.
Germany news
For more Germany news, you can click here:
more Germany newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsYahoo Finance news
For more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
development company Evotec. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Evotec news, Novo news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Novo NordiskReuters
•Evotec and Novo Nordisk in technology development partnership
83% Informative
Evotec will receive funding for technology development activities in Germany and Italy , research and development funding, an undisclosed upfront payment and possible milestone and royalty payments.
Stem cell-based therapies at Novo Nordisk are still at an exploratory level within diabetes and cardiovascular diseases.
VR Score
92
Informative language
97
Neutral language
81
Article tone
formal
Language
English
Language complexity
75
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links